ஜெனிபர் விர News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from ஜெனிபர் விர. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In ஜெனிபர் விர Today - Breaking & Trending Today
Enanta Pharmaceuticals, inc (ENTA) Q3 2021 Earnings Call Transcript fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Operator Good afternoon, and welcome to Enanta Pharmaceuticals First Quarter 2021 Financial Results Conference Call. [Operator Instructions] There will be a question-and-answer session at the end of the prepared remarks. [Operator Instructions] I would now like to turn the conference over to Jennifer Viera, Investor Relations. Please go ahead. Jennifer Viera Investor Relations Thank you, operator, and thank you to everyone for joining us this afternoon. The news release with our fiscal first quarter financial results was issued this afternoon and is available on our website. On the call today is Dr. Jay Luly, President and Chief Executive Officer; Paul Mellett, our Chief Financial Officer; and other members of Enanta s senior management team. ....
Press release content from Business Wire. The AP news staff was not involved in its creation. Enanta Pharmaceuticals Announces the Appointment of Brendan Luu as Senior Vice President, Business Development January 26, 2021 GMT Brendan Luu, Senior Vice President, Business Development, Enanta Pharmaceuticals (Photo: Business Wire) WATERTOWN, Mass. (BUSINESS WIRE) Jan 26, 2021 Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced the appointment of Brendan Luu as Senior Vice President, Business Development and member of the company’s senior management team. Mr. Luu brings more than 20 years of diversified business development and sales and marketing experience in the pharmaceutical and technology fields to Enanta, spanning a broad range of therapeutic areas, asset stages and deal structures. ....